Retour
Fourchette du Jour
41,32 €
41,32 €
Fourchette 52 Semaines
25,80 €
42,22 €
Volume
100
Moyenne 50J / 200J
38,09 €
/
33,40 €
Clôture Précédente
41,32 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 30,0 | 0,4 |
| P/B | 0,4 | 2,9 |
| ROE % | 1,2 | 3,9 |
| Net Margin % | 1,7 | 3,8 |
| Rev Growth 5Y % | 16,1 | 10,0 |
| D/E | 0,3 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
34,41 €
33,72 € – 35,14 €
|
48,31B | 1 |
| FY2029 |
31,00 €
30,38 € – 31,65 €
|
44,85B | 1 |
| FY2028 |
25,51 €
25,00 € – 26,05 €
|
39,60B | 1 |
No quarterly estimates available
Dividend History
Yield
0,00%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue grew 16,05% annually over 5 years — strong growth
Earnings declined -87,73% over the past year
ROE of 1,22% is below average
Debt/Equity of 0,31 — conservative balance sheet
Generating 8,50B in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 7,83%
Croissance
Revenue Growth (5Y)
16,05%
Revenue (1Y)8,22%
Earnings (1Y)-87,73%
FCF Growth (3Y)N/A
Qualité
Return on Equity
1,22%
ROIC12,20%
Net Margin1,69%
Op. Margin28,50%
Sécurité
Debt / Equity
0,31
Current Ratio0,90
Interest Coverage9,68
Valorisation
P/E Ratio
29,96
Forward P/EN/A
P/B Ratio0,38
EV/EBITDA3,11
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8,22% | Revenue Growth (3Y) | 12,84% |
| Earnings Growth (1Y) | -87,73% | Earnings Growth (3Y) | -55,51% |
| Revenue Growth (5Y) | 16,05% | Earnings Growth (5Y) | -35,05% |
| Profitability | |||
| Revenue (TTM) | 28,17B | Net Income (TTM) | 476,80M |
| ROE | 1,22% | ROA | 0,71% |
| Gross Margin | 43,63% | Operating Margin | 28,50% |
| Net Margin | 1,69% | Free Cash Flow (TTM) | 8,50B |
| ROIC | 12,20% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,31 | Current Ratio | 0,90 |
| Interest Coverage | 9,68 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 29,96 | Forward P/E | N/A |
| P/B Ratio | 0,38 | P/S Ratio | 0,51 |
| PEG Ratio | -2,67 | Forward PEG | N/A |
| EV/EBITDA | 3,11 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 59,53% | ||
| Market Cap | 14,28B | Enterprise Value | 24,97B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 28,17B | 26,03B | 22,12B | 18,79B | 15,53B |
| Net Income | 476,80M | 3,89B | 2,41B | 2,64B | 2,68B |
| EPS (Diluted) | 1,38 | 11,24 | 7,39 | 8,44 | 8,62 |
| Gross Profit | 12,29B | 20,24B | 17,13B | 14,01B | 12,05B |
| Operating Income | 8,03B | 5,63B | 4,07B | 3,81B | 3,73B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 67,26B | 75,44B | 74,03B | 52,50B | 48,66B |
| Total Liabilities | 29,64B | 35,15B | 40,16B | 25,97B | 25,46B |
| Shareholders' Equity | 37,62B | 40,29B | 33,87B | 26,53B | 23,20B |
| Total Debt | 11,72B | 16,74B | 20,49B | 9,10B | 10,91B |
| Cash & Equivalents | 1,04B | 1,14B | 904,00M | 1,36B | 1,05B |
| Current Assets | 14,49B | 13,16B | 12,67B | 11,21B | 8,78B |
| Current Liabilities | 16,03B | 12,60B | 19,10B | 14,86B | 8,76B |
Scores de Stratégies
This stock passed the criteria for 3 strategies
Score = fit strength (0–100)
Rank = position among all matches
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026
Entré
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entré
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026